Yi-Syuan Yen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Yi-Syuan Yen has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Akbar K. Waljee
Center for Global Health Equity, Michigan Medicine, University of Michigan, Ann Arbor, Michigan, USA
1 shared publication - Asgeir Johannessen
Department of Infectious Diseases Vestfold Hospital Tønsberg Norway
1 shared publication - Brooke Kenney
Menelik II Medical and Health Science College, Addis Ababa, Ethiopia
1 shared publication - Geoffrey Henry Siwo
Department of Learning Health Sciences, University of Michigan Medical School, United States
1 shared publication - Hailemichael Desalegn
Department of Internal Medicine, St. Paul’s Hospital Millennium Medical College, Addis Ababa, Ethiopia
1 shared publication - Ji Zhu
Department of Statistics, University of Michigan
1 shared publication
Latest Publications
- Open Access
- 15 November 2024
- Published by Wolters Kluwer Health in Hepatology Communications
- Vol. 8 (12)
Machine-learning methodologies to predict disease progression in chronic hepatitis B in Africa
Background: Little is known about the determinants of disease progression among African patients with chronic HBV infection. Methods: We used machine-learning models with longitudinal data to establish predictive algorithms in a well-characterized cohort of Ethiopian HBV-infected patients without baseline liver fibrosis. Disease progression was defined as an increase in liver stiffness to >7.9 kPa or initiation of treatment based on meeting the eligibility criteria. Results: Twenty-four of 551 patients (4.4%) experienced disease progression after a median follow-up time of 69 months. A random forest model based on a combination of available laboratory tests (standard hematology and biochemistry) demonstrated the best predictive properties with the AUROC ranging from 0.82 to 0.88. Conclusion: We conclude that combined metrics based on simple and available laboratory tests had good predictive properties and should be explored further in larger HBV cohorts.
- 15 November 2024
- Published by Wolters Kluwer Health in Hepatology Communications
- Vol. 8 (12)
Open AccessMachine-learning methodologies to predict disease progression in chronic hepatitis B in Africa
Background: Little is known about the determinants of disease progression among African patients with chronic HBV infection. Methods: We used machine-learning models with longitudinal data to establish predictive algorithms in a well-characterized cohort of Ethiopian HBV-infected patients without baseline liver fibrosis. Disease progression was defined as an increase in liver stiffness to >7.9 kPa or initiation of treatment based on meeting the eligibility criteria. Results: Twenty-four of 551 patients (4.4%) experienced disease progression after a median follow-up time of 69 months. A random forest model based on a combination of available laboratory tests (standard hematology and biochemistry) demonstrated the best predictive properties with the AUROC ranging from 0.82 to 0.88. Conclusion: We conclude that combined metrics based on simple and available laboratory tests had good predictive properties and should be explored further in larger HBV cohorts.